Kafadar, A. Et Al. 2014. Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?. FEBS EMBO 2014 Conference , (Paris, France), 76.

Kafadar, A., Kucukhuseyin, Ö., Cacina, C., Yenilmez, E. N., Turan, S., Kafadar, D., ... Ozkok, E.(2014). Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors? . FEBS EMBO 2014 Conference (pp.76). Paris, France

Kafadar, Ali Et Al. "Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?," FEBS EMBO 2014 Conference, Paris, France, 2014

Kafadar, Ali M. Et Al. "Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?." FEBS EMBO 2014 Conference , Paris, France, pp.76, 2014

Kafadar, A. Et Al. (2014) . "Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?." FEBS EMBO 2014 Conference , Paris, France, p.76.

@conferencepaper{conferencepaper, author={Ali Metin KAFADAR Et Al. }, title={Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?}, congress name={FEBS EMBO 2014 Conference}, city={Paris}, country={France}, year={2014}, pages={76} }